Name | Isopropyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-glucopyranoside |
---|---|
Synonyms |
α-D-Glucopyranoside, 1-methylethyl 2-(acetylamino)-2-deoxy-, 3,4,6-triacetate
Isopropyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-glucopyranoside MFCD28053519 TLR4-IN-C34 |
Description | TLR4-IN-C34 is an orally active TLR4 inhibitor and reduces systemic inflammation in models of endotoxemia and necrotizing enterocolitis[1][2]. |
---|---|
Related Catalog | |
In Vivo | TLR4-IN-C34 (C34, 1 mg/kg, orally daily) could attenuate NEC severity and demonstrates a marked preservation of the intestinal mucosa[1]. Animal Model: Experimental NEC induced in 7-8 day old mice[1]. Dosage: 1 mg/kg. Administration: Orally every morning. Result: Attenuated intestinal inflammation. |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Boiling Point | 519.8±50.0 °C at 760 mmHg |
Molecular Formula | C17H27NO9 |
Molecular Weight | 389.398 |
Flash Point | 268.2±30.1 °C |
Exact Mass | 389.168579 |
LogP | 0.83 |
Vapour Pressure | 0.0±1.4 mmHg at 25°C |
Index of Refraction | 1.484 |
RIDADR | NONH for all modes of transport |
---|